Tunis, Tunisia | Xinhua | Tunisian Health Ministry decided to suspend using the Johnson & Johnson COVID-19 vaccine (Janssen), the official Tunis Afrique Presse reported on Monday. The Health Minister Ali Mrabet said at a press conference on Monday that Tunisian government made this decision after the U.S. Food and Drug …
Read More »Moderna to request FDA’s approval for vaccinating children aged under 6
Los Angeles, U.S. | Xinhua | American biotechnology company Moderna said Wednesday it will request the U.S. Food and Drug Administration (FDA) to grant emergency use authorization for its COVID-19 vaccine for children aged under 6. The company will submit the request to the FDA, as well as the European Medicines …
Read More »U.S. FDA okays emergency use of molnupiravir pill for COVID-19
Washington, U.S. | Xinhua | The U.S. Food and Drug Administration (FDA) on Thursday authorized American pharmaceutical company Merck’s oral antiviral for the treatment of mild-to-moderate COVID-19, the second pill approved for treating COVID-19 following the one from Pfizer. Merck’s pill, called molnupiravir, is authorized to use in adults with positive …
Read More »U.S. FDA authorizes first oral antiviral for COVID-19 treatment
Washington, U.S. | Xinhua | The U.S. Food and Drug Administration on Wednesday authorized Pfizer’s oral antiviral tablets for the treatment of mild-to-moderate COVID-19, the first pill approved for COVID-19 treatment in the country. The pill, called Paxlovid, is authorized for use in adults and pediatric patients 12 years of age …
Read More »U.S. authorizes Pfizer/BioNTech, Moderna COVID-19 vaccine boosters for all adults
New York, U.S. | Xinhua | The U.S. Food and Drug Administration (FDA) on Friday authorized boosters of the Pfizer/BioNTech and Moderna COVID-19 vaccines for all adults. The agency expanded emergency use authorization for booster doses of both the mRNA vaccines beyond who was previously eligible — boosters had been authorized …
Read More »Pfizer asks U.S. FDA to authorize COVID-19 booster for all 18 and up
New York, U.S. | Xinhua | Drugmakers Pfizer and BioNTech said on Tuesday that they had asked the U.S. Food and Drug Administration (FDA) to authorize booster shots of their COVID-19 vaccine for all adults 18 years old and over, seeking to broaden who is eligible for a third shot. The …
Read More »White House unveils plan to roll out COVID-19 vaccines for children ages 5 to 11
Washington, U.S. | Xinhua | The White House on Wednesday unveiled its plan to roll out COVID-19 vaccines for children ages 5 to 11, pending the vaccine’s approval by the U.S. Food and Drug Administration (FDA). “In anticipation of the FDA’s independent advisory committee meeting on October 26 and the CDC’s …
Read More »U.S. FDA approves Moderna, J&J COVID-19 boosters, allows ‘mix and match’ shots
Washington, U.S. | Xinhua | The U.S. Food and Drug Administration (FDA) on Wednesday authorized COVID-19 booster doses of Moderna and Johnson & Johnson, and approved “mix and match” booster dose for currently available approved COVID-19 vaccines. The agency authorized the use of a single booster dose of the Moderna COVID-19 …
Read More »U.S. FDA adds warning on Johnson & Johnson vaccine related to rare neurological disorder
Washington, U.S. | Xinhua | The U.S. Food and Drug Administration (FDA) added a new warning on the Johnson & Johnson COVID-19 vaccine on Monday, saying the vaccine has been linked to a serious but rare side effect called Guillain-Barre syndrome. Guillain Barre syndrome is a neurological disorder in which the …
Read More »FDA authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine in adolescents
Chicago, USA | XINHUA | U.S. Food and Drug Administration (FDA) on Monday authorized the emergency use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 for the prevention of COVID-19 vaccine caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The FDA has determined that Pfizer-BioNTech COVID-19 Vaccine has …
Read More »